Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of a Facial Toner with Hydroquinone for Hyperpigmentation
NCT07136766Phase 3Completed
- Start
- Sep 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 3, randomised trial in Hyperpigmentation and melasma (2 arms). Primary endpoints: Skin Lightness (L*) at 18 weeks and Erythema (a*) at 18 weeks. Started Sep 2025; status: completed.
02
Conditions
Hyperpigmentationmelasma
Beyond the preview
Go deeper on NCT07136766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07136766.